The association between FANCC (FA Complementation Group C) and Ovarian Cancer is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording likely-pathogenic variants.
Sources2
Clinical variants5
Symptoms8
Compounds3
Trials200of 5,831 via FANCC compounds
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.